Motrin and Advil are two of the most widely used over-the-counter (OTC) pain relievers. Both medications contain ibuprofen, an anti-inflammatory drug that works to reduce pain, fever, and inflammation. While both medications are effective in treating these symptoms, there are some differences between them that doctors should be aware of when recommending one over the other. This article will provide a comprehensive comparison of Motrin and Advil, including their active ingredients, dosage forms, side effects, and contraindications.
The active ingredient in both Motrin and Advil is ibuprofen. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that works by blocking the production of certain chemicals in the body that cause pain and inflammation. Ibuprofen is available in both over-the-counter and prescription strengths. The active ingredient in Motrin is ibuprofen lysine, while the active ingredient in Advil is ibuprofen sodium. The difference between the two is that ibuprofen lysine is slightly more soluble in water than ibuprofen sodium, which means it is absorbed faster into the bloodstream.
Motrin and Advil are both available in a variety of dosage forms, including tablets, capsules, liquids, and gels. Motrin is also available as an oral suspension, while Advil is available as an oral suspension and a chewable tablet. The recommended dosages for Motrin and Advil vary depending on the age and weight of the patient. Generally, the recommended dose for adults is 200-400mg every 4-6 hours, not exceeding 1200mg per day. For children, the recommended dose is 10-15mg/kg/day, divided into 3-4 doses.
The most common side effects of Motrin and Advil are nausea, stomach pain, and diarrhea. Other potential side effects include dizziness, headache, drowsiness, and rash. In some cases, these medications can cause more serious side effects, such as liver or kidney damage, or an allergic reaction. If any of these side effects occur, the patient should seek medical attention immediately.
Motrin and Advil should not be used in patients with a known allergy to ibuprofen, or those with a history of stomach ulcers, kidney or liver disease, or bleeding disorders. In addition, Motrin and Advil should not be used in combination with other NSAIDs, such as aspirin or naproxen, as this can increase the risk of side effects.
Motrin and Advil are two of the most commonly used OTC pain relievers. Both medications contain ibuprofen, an anti-inflammatory drug that works to reduce pain, fever, and inflammation. While both medications are effective in treating these symptoms, doctors should be aware of the differences between them, including their active ingredients, dosage forms, side effects, and contraindications. It is important for patients to follow the instructions on the medication packaging and seek medical attention if any side effects occur.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation